drugset / Trial / NCT04724772

Use of Tranexamic Acid in Blepharoplasties

NCT04724772

Phase 3 Withdrawn Northwestern University
NaSingle-groupOpen-labelPrevention

Summary

The goal of this investigation is to assess whether or not there is a significant difference in the presence and/or degree of post-operative ecchymosis, pain, and edema between groups of patients undergoing upper lid blepharoplasty with traditional local anesthetic (LA) and those who receive tranexamic acid (TXA) in addition to traditional LA.

Timeline

Start
2020-02-20
Primary completion
2023-07-20
Completion
2023-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule Other

Indications

No indication recorded.